Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2011

Open Access 01-12-2011 | Case report

Peritoneal mesothelioma in a woman who has survived for seven years: a case report

Authors: Krishna Pillai, Javed Akhter, Mohammad H Pourgholami, David L Morris

Published in: Journal of Medical Case Reports | Issue 1/2011

Login to get access

Abstract

Introduction

Malignant peritoneal mesothelioma is a rare cancer with poor patient survival. Female gender has been identified as a positive prognostic factor. Recently, it has been suggested that the expression of estrogen receptor β in malignant mesothelioma leads to tumor suppression and a better prognosis.

Case presentation

We report the case of a 48-year-old Caucasian woman who is alive and disease-free seven years after the initial diagnosis and treatment of malignant peritoneal mesothelioma.

Conclusion

This patient's long survival may be attributable to a combination of factors, including minimal disease, complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy plus the estrogen receptor β positivity of the tumor.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ahmed I, Koulaouzidis A, Iqbal J, Tan WC: Malignant peritoneal mesothelioma as a are cause of ascites: a case report. J Med Case Reports. 2008, 2: 121-124. 10.1186/1752-1947-2-121.CrossRefPubMedCentral Ahmed I, Koulaouzidis A, Iqbal J, Tan WC: Malignant peritoneal mesothelioma as a are cause of ascites: a case report. J Med Case Reports. 2008, 2: 121-124. 10.1186/1752-1947-2-121.CrossRefPubMedCentral
2.
go back to reference Lee AM, Raz DJ, He B, Jablons DM: Update of the molecular biology of malignant mesothelioma. Cancer. 2007, 109: 1454-1461. 10.1002/cncr.22552.CrossRefPubMed Lee AM, Raz DJ, He B, Jablons DM: Update of the molecular biology of malignant mesothelioma. Cancer. 2007, 109: 1454-1461. 10.1002/cncr.22552.CrossRefPubMed
3.
go back to reference Boffetta P: Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007, 18: 985-990. 10.1093/annonc/mdl345.CrossRefPubMed Boffetta P: Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007, 18: 985-990. 10.1093/annonc/mdl345.CrossRefPubMed
4.
go back to reference Cutrone R, Lidnisk J, Dunn G, Rizzo P, Bocchetta M, Chumakov K, Minor P, Carbone M: Some oral poliovirus vaccine were contaminated with infectious SV40 after 1961. Cancer Res. 2005, 65: 10273-10279. 10.1158/0008-5472.CAN-05-2028.CrossRefPubMed Cutrone R, Lidnisk J, Dunn G, Rizzo P, Bocchetta M, Chumakov K, Minor P, Carbone M: Some oral poliovirus vaccine were contaminated with infectious SV40 after 1961. Cancer Res. 2005, 65: 10273-10279. 10.1158/0008-5472.CAN-05-2028.CrossRefPubMed
5.
go back to reference Mohammad F, Sugarbaker PH: Peritoneal mesothelioma. Curr Treat Options Oncol. 2002, 3: 375-386. 10.1007/s11864-002-0003-6.CrossRef Mohammad F, Sugarbaker PH: Peritoneal mesothelioma. Curr Treat Options Oncol. 2002, 3: 375-386. 10.1007/s11864-002-0003-6.CrossRef
6.
go back to reference Chua TC, Yan TD, Morris DL: Peritoneal mesothelioma: current understanding and management. Can J Surg. 2009, 52: 59-64.PubMedPubMedCentral Chua TC, Yan TD, Morris DL: Peritoneal mesothelioma: current understanding and management. Can J Surg. 2009, 52: 59-64.PubMedPubMedCentral
7.
go back to reference Feldman AL, Libutti SK, PingPank JF, Bartlett DL, Beresnev TH, Mavroukakis SM, Steinberg SM, Liewehr DJ, Kleiner DE, Alexander HR: Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol. 2003, 21: 4560-4566. 10.1200/JCO.2003.04.150.CrossRefPubMed Feldman AL, Libutti SK, PingPank JF, Bartlett DL, Beresnev TH, Mavroukakis SM, Steinberg SM, Liewehr DJ, Kleiner DE, Alexander HR: Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol. 2003, 21: 4560-4566. 10.1200/JCO.2003.04.150.CrossRefPubMed
8.
go back to reference Bridda A, Padoan I, Mencarelli R, Frego M: Peritoneal mesothelioma: a review. Med Gen Med. 2007, 9: 32. Bridda A, Padoan I, Mencarelli R, Frego M: Peritoneal mesothelioma: a review. Med Gen Med. 2007, 9: 32.
9.
go back to reference Pinton G, Brunelli E, Murer B, Puntoni R, Puntoni M, Fennell DA, Gaudino G, Mutti L, Moro L: Estrogen receptor β affects the prognosis of human malignant mesothelioma. Cancer Res. 2009, 11: 4598-4604. 10.1158/0008-5472.CAN-08-4523.CrossRef Pinton G, Brunelli E, Murer B, Puntoni R, Puntoni M, Fennell DA, Gaudino G, Mutti L, Moro L: Estrogen receptor β affects the prognosis of human malignant mesothelioma. Cancer Res. 2009, 11: 4598-4604. 10.1158/0008-5472.CAN-08-4523.CrossRef
10.
go back to reference Osborne CK, Schiff R: Estrogen receptor biology: continuing progress and therapeutic implications. J Clin Oncol. 2005, 23: 1616-1622. 10.1200/JCO.2005.10.036.CrossRefPubMed Osborne CK, Schiff R: Estrogen receptor biology: continuing progress and therapeutic implications. J Clin Oncol. 2005, 23: 1616-1622. 10.1200/JCO.2005.10.036.CrossRefPubMed
Metadata
Title
Peritoneal mesothelioma in a woman who has survived for seven years: a case report
Authors
Krishna Pillai
Javed Akhter
Mohammad H Pourgholami
David L Morris
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2011
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-5-36

Other articles of this Issue 1/2011

Journal of Medical Case Reports 1/2011 Go to the issue